InvestorsHub Logo
Followers 972
Posts 383067
Boards Moderated 5
Alias Born 06/24/2011

Re: None

Tuesday, 02/23/2021 3:46:12 PM

Tuesday, February 23, 2021 3:46:12 PM

Post# of 580
Charles Martin, President and CEO of CB Scientific, Inc. stated, “The acquisition of Cardiolink Corporation fits perfectly into our strategic plan and efforts to positively impact outcomes for the more than 655,000 Americans who die from heart disease in the United States every year. Cardiovascular disease is the leading cause of death in the US, killing one in every four people every year, and costing the US more than $219B annually. The addition of this well-established, proven company, along with our existing and future products and services, will help to solidify CBSC's expanded service offering in our efforts to become a leader in the US Remote Patient Monitoring market. Timely and early detection of potential heart rhythm issues is the key to better diagnosis and improved outcomes, reducing cost and helping to improve quality of life for patients.

$CBSC